Last reviewed · How we verify
NCT02033642: HealthU
A Family-Based Weight Loss Intervention for Youth With Intellectual Disability
NA trial testing Family Based Behavioral Intervention in Obesity in 31 participants. Completed in 19 January 2018.
19 January 2018
Quick facts
| Lead sponsor | University of Massachusetts, Boston |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 31 |
| Start date | 22 August 2012 |
| Primary completion | 19 January 2018 |
| Estimated completion | 19 January 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Family Based Behavioral Intervention
- Maintenance — full drug profile →
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
University of Massachusetts, Boston
Who can join
Adults 14 to 22, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this randomized controlled trial is twofold. First, to examine the efficacy of a 24-session, 6-month family-based behavioral intervention (FBBI) - as compared to a waitlist FBBI group, which later receives the same FBBI - that targets weight loss in adolescents/young adults with intellectual disability aged 14-22 years. Second, to examine the efficacy of a 12-session, 6-month Maintenance intervention that targets maintenance of weight loss in the same population of adolescents/young adults with intellectual disability. The Maintenance condition follows the completion of each FBBI group and involves a re-randomization to either the Maintenance intervention or no further intervention. Primary outcome measures include body weight and Body Mass Index (BMI). Secondary outcome measures include physical activity/sedentary behavior (measured via accelerometry), dietary patterns (3-Day Food Records), and self-efficacy (brief questionnaire). Hypotheses are that: (1) participants in the FBBI condition will lose more weight (and reduced BMI) than participants in the waitlist treatment condition, and that (2) participants in the Maintenance condition will maintain weight lost (and reductions in BMI) or experience less weight regain, as compared with participants who receive no further intervention following FBBI.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A family-based weight loss randomized controlled trial for youth with intellectual disabilities.
Bandini LG, Eliasziw M, Dittrich GA, Curtin C, et al · · 2021 · cited 8× · PMID 34076370 · DOI 10.1111/ijpo.12816
Verify or expand the search:
- PubMed search for NCT02033642
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other University of Massachusetts, Boston trials
Trials by the same sponsor.
- NCT03705598 — Tai Chi Intervention for Geriatric Pain Syndrome · NA · not yet recruiting
- NCT05685082 — Teaching the Social Determinants of Health to Nursing Students With Simulation · NA · completed
- NCT04307433 — Storytelling Intervention to Promote Cervical Cancer Screening Uptakes Among Malawian Women Living With Human Immunodefi · NA · completed
- NCT03720600 — Forms of Racial Discrimination Study · NA · completed
- NCT03289676 — Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV · Phase 1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02033642 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Boston
- Last refreshed: 18 December 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02033642.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing